---
title: Uretal Flow Assessment During Gynecological Procedures
nct_id: NCT00453882
overall_status: COMPLETED
phase: NA
sponsor: Ethicon, Inc.
study_type: INTERVENTIONAL
primary_condition: Conservative Gynecological Procedures
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00453882.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00453882"
ct_last_update_post_date: 2012-01-30
last_seen_at: "2026-05-12T06:56:18.485Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Uretal Flow Assessment During Gynecological Procedures

**Official Title:** An Evaluation of Ureteral Flow After Temporary Bilateral Uterine Artery Occlusion During Conservative Gynecological Procedures

**NCT ID:** [NCT00453882](https://clinicaltrials.gov/study/NCT00453882)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 7
- **Lead Sponsor:** Ethicon, Inc.
- **Conditions:** Conservative Gynecological Procedures
- **Start Date:** 2006-11
- **Completion Date:** 2007-04
- **CT.gov Last Update:** 2012-01-30

## Brief Summary

The objective is to evaluate the feasibility of using color Doppler ultrasound in ureteral flow assessment after uterine artery occlusion during a conservative gynecological procedure.

## Eligibility

- **Minimum age:** 25 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Meets criteria for conservative gynecological procedure
* At least 25 years of age
* Cervix suitable for tenaculum placement
* Provides written informed consent.

Exclusion Criteria:

* Pregnancy
* One or more lower uterine segment fibroids
* Hydronephrosis as determined by renal ultrasound pre-procedurally
* Clinical diagnosis of urinary tract infection (UTI)
* In the medical judgment of the physician, such a procedure may compromise the patient's condition
* Inability to achieve bilateral occlusion with the clamp placement during the procedure.
```

## Interventions

- **flostat (TM) System** (DEVICE)

## Primary Outcomes

- **Ability to evaluate ureteric jets**
- **Adverse events**

## Locations (1)

- Holy Cross Medical Group, Fort Lauderdale, Florida, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.holy cross medical group|fort lauderdale|florida|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00453882.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00453882*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*